Clovis Oncology Inc. (CLVS) Surged 7.06% or 2.97 To Price $45.03 On Wednesday

Clovis Oncology Inc. (CLVS) surged 7.06% or 2.97 to $45.03. It is approximately 1.74 million shares traded, which is 161.25% compare to the average total volume 1.08 million. The market cap of CLVS is $2.37 billion. The year to date change is 669.78%. The 52 week price range is from $41.31 to $99.45. Price of CLVS have changed -11.19% during last week. It have changed -15.91% over last month, -32.53% over last 3 months, -32.74% over last 6 months and -30.00% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLVS is 49.31. It is 9.50% above current price. The 200-day Moving Averages for CLVS is 61.75. It is 37.13% above current price. The 52-week High is 99.45. It is 120.85% from the current price. The 52-week Low is 41.31. It is -8.26% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLVS is 6.72 on 2018-05-31. Short % to float is 14.89%. There are some statistics of CLVS. It is has market cap $2.37 billion. The share outstanding is 52.55 million. The average volume is 1.08 million. The revenue is 31.43M. The gross profit is 24.93M. The percent of top 15 Institution holding is 86.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLVS is -152.20%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLVS is -60.16%.


Share this post